The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

Sonder Medicine Inc.

Sonder Medicine uses extracellular vesicles from the vitreous humor as a potent vector to efficiently deliver recombinant proteins into the sensory tissue of the eye, the retina. Their proprietary technology can transport various payloads, including therapeutic proteins, nucleic acids and antibodies into the tissues of the human eye.

 

Aufbau Medical Innovations Ltd., wholly owns Sonder Medicine Inc., doing business as Sonder Research X in the United States.

 

Location: Dublin, Ireland / Ithaca, NY

Foundation Cornell Technology Licensed: 2019